In conclusion, we have elucidated the tight regulatory network of miR-6086 that interacts with the OC2/VEGFA/EGFL6 axis and our study reveals a promising insight into understanding their roles of tumorigenesis and angiogenesis in ovarian cancer, ultimately providing potential molecular targets for anti-tumor therapeutics. This evidence concerns the gene EGFL6 and ovarian carcinoma.